The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
880
October 2, 1992
View Complete Issue         Table of Contents 2019 
Prostate Specific Antigen
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Prostate Specific Antigen
October 2, 1992 (Issue: 880)
Serum measurements of prostate specific antigen (PSA) are now being used in the diagnosis and management of prostate cancer. Produced by prostatic epithelium, PSA is a protease involved in liquefaction of the seminal coagulum. Whether this test...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Prostate Specific Antigen
Article code: 880b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.